Skip to content

Middle-aged people living with HIV have an increased risk of frailty

HIV salvage regimens can safely omit NRTIs, says US study

Tenofovir alafenamide fumarate at what price? No more than $1000 a year above existing tenofovir formulation, says model

Two-drug ART with dolutegravir-lamivudine would be cost-effective and achieve substantial cash savings

Drug resistance acquired during HIV PrEP rapidly disappears after medication is discontinued

Ipergay PrEP study results published

WHO issues recommendations on linkage to care, retention, to help bring HIV treatment to all

Two-drug maintenance therapy keeps viral load suppressed and may even have advantages over traditional ART

Dutch research identifies relationship between HIV clinic characteristics and retention of patients in care